A nurse is reinforcing teaching with a middle adult female client who has fibrocystic breast disease. The nurse should emphasize to the client that manifestations of this disease are present at which of the following times?
During cold weather
Before menstruation begins
After menstruation ends
During hot weather
The Correct Answer is B
A. During cold weather: Weather conditions do not typically affect the manifestations of fibrocystic breast disease.
B. Before menstruation begins: Manifestations of fibrocystic breast disease, such as breast pain and lumpiness, tend to occur or worsen in the premenstrual phase of the menstrual cycle.
C. After menstruation ends: Manifestations of fibrocystic breast disease are typically most prominent before menstruation rather than after it ends.
D. During hot weather: Weather conditions do not typically affect the manifestations of fibrocystic breast disease.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is A
Explanation
A. Raloxifene hydrochloride is a selective estrogen receptor modulator (SERM) that is used for the prevention and treatment of osteoporosis in postmenopausal women. It helps to prevent bone loss and reduce the risk of fractures by acting similarly to estrogen in some tissues and antagonizing estrogen in others.
B. Levothyroxine is a thyroid hormone replacement medication used to treat hypothyroidism, not osteoporosis.
C. Escitalopram oxalate is an antidepressant medication used to treat depression and anxiety disorders, not osteoporosis.
D. Calcitonin is a hormone involved in calcium regulation, and calcitonin nasal spray is sometimes used in the treatment of osteoporosis, but it is not typically the first-line treatment option.
Correct Answer is B
Explanation
A. Reticulocyte count: Reticulocyte count measures immature red blood cells and is not the primary measure for the effectiveness of filgrastim, which is used to boost white blood cells.
B. White blood count / Absolute neutrophil count: Filgrastim (Neupogen) is used to increase white blood cells, specifically neutrophils. Therefore, monitoring the white blood count (WBC) and absolute neutrophil count (ANC) is the appropriate way to determine the effectiveness of the drug.
C. Total lymphocyte count: While lymphocytes are a type of white blood cell, filgrastim primarily affects neutrophils, making WBC/ANC a better indicator.
D. Platelet count: Filgrastim does not directly impact platelet production, so platelet count is not the primary measure of its effectiveness.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.